Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1541-1550 of 1,553) with videos related to

Pageof 156
Sort By:
The Lancet. Oncology|February 14, 2025
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trialXiaotian Zhang, Han Liang, Ziyu Li, et al.
Cancer Communications (London, England)|July 1, 2021
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021Feng-Hua Wang, Xiao-Tian Zhang, Yuan-Fang Li, et al.
Cancer Communications (London, England)|December 31, 2023
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, et al.
Journal of the National Cancer Center|July 22, 2024
Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancerJiujie Cui, Feng Jiao, Qi Li, et al.
Journal of Orthopaedic Translation|November 16, 2022
Denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women: A randomized, double-blind, placebo-controlled, multicenter phase III studyJiemei Gu, Hao Zhang, Qingyun Xue, et al.
The Lancet. Oncology|October 5, 2023
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trialXiangyu Gao, Nong Xu, Ziyu Li, et al.
Cancer Biology & Medicine|May 24, 2019
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical OncologyXuchao Zhang, Zhiyong Liang, Shengyue Wang, et al.
Nature|February 28, 2020
Epigenetic therapy inhibits metastases by disrupting premetastatic nichesZhihao Lu, Jianling Zou, Shuang Li, et al.
JCO Precision Oncology|March 30, 2023
PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective StudyMifen Chen, Zhenghang Wang, Zimin Liu, et al.
Cancer Cell|March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialZi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Pageof 156

Showing results (1541-1550 of 1,553) with videos related to

Sort By:
Pageof 156
The Lancet. Oncology|February 14, 2025
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): final report of a randomised, open-label, phase 3 trialXiaotian Zhang, Han Liang, Ziyu Li, et al.
Cancer Communications (London, England)|July 1, 2021
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021Feng-Hua Wang, Xiao-Tian Zhang, Yuan-Fang Li, et al.
Cancer Communications (London, England)|December 31, 2023
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023Feng-Hua Wang, Xiao-Tian Zhang, Lei Tang, et al.
Journal of the National Cancer Center|July 22, 2024
Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of pancreatic cancerJiujie Cui, Feng Jiao, Qi Li, et al.
Journal of Orthopaedic Translation|November 16, 2022
Denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women: A randomized, double-blind, placebo-controlled, multicenter phase III studyJiemei Gu, Hao Zhang, Qingyun Xue, et al.
The Lancet. Oncology|October 5, 2023
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trialXiangyu Gao, Nong Xu, Ziyu Li, et al.
Cancer Biology & Medicine|May 24, 2019
Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical OncologyXuchao Zhang, Zhiyong Liang, Shengyue Wang, et al.
Nature|February 28, 2020
Epigenetic therapy inhibits metastases by disrupting premetastatic nichesZhihao Lu, Jianling Zou, Shuang Li, et al.
JCO Precision Oncology|March 30, 2023
PD-1/PD-L1 Inhibitor Plus Chemotherapy Versus PD-1/PD-L1 Inhibitor in Microsatellite Instability Gastrointestinal Cancers: A Multicenter Retrospective StudyMifen Chen, Zhenghang Wang, Zimin Liu, et al.
Cancer Cell|March 4, 2022
Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trialZi-Xian Wang, Chengxu Cui, Jun Yao, et al.
Pageof 156